Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03954431

High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)

This study is being performed to find out if a new kind of breast imaging (called dedicated breast CT or BCT) can help doctors to see the small structures in breast tissue more clearly. The investigators also want to find out if using the BCT will provide a more accurate diagnosis of breast cancer.

Recruiting

Interested in participating?

Request Info

Key information

Age range

40 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Arizona

Tucson, Arizona, 85724, United States

Location status: Recruiting

Location contact

Alan J-T Chiang, MD, PhD

SUB_INVESTIGATOR

Michele Galvan, R.T.

CONTACT

[email protected]

520-626-2279

Srinivasan Vedantham, PhD

PRINCIPAL_INVESTIGATOR

About this study

The breast imaging device that will be used in this study (breast computed tomography or BCT) is not FDA-approved for this use so this is a research study. The machine has been redesigned to see if doctors can see smaller structures and use a lower radiation dose.

The breast CT device will take multiple pictures of the subject's breast and create a 3-D image of the breast. It does not compress or squash the breast like a mammogram.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All subjects that are eligible to participate in the study will be women who satisfy all of the inclusion criteria stated below:

  • who are 40 years of age or older (typical screening age range)
  • who are undergoing or scheduled for screening or diagnostic imaging, or need a biopsy to investigate an abnormality in the breast.

Exclusion criteria

Subjects that present with any of the criteria listed below will be excluded:

  • Males,
  • women less than 40 years old,
  • women unable to self-consent,
  • prisoners,
  • pregnant, suspected to be pregnant, or lactating women (self-reported)
  • women with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker;
  • women who are unable to tolerate study constraints, frail, or unable to cooperate;
  • women who weigh more than 440 lbs (200 Kg), which is the weight limit for the patient support table of the BCT system;
  • women who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to) treatment for enlarged thymus gland as an infant, irradiation for benign breast conditions, including breast inflammation after giving birth, and treatment for Hodgkin's disease;
  • women who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram;
  • women who have received large number of diagnostic x-ray examinations for monitoring of disease such as (but not limited to) tuberculosis, and severe scoliosis.

Treatment and study plan

Dedicated breast CT(BCT)

Diagnostic Test

The breast CT device will take multiple pictures of the subject's uncompressed breast and creates a 3-D image of the breast.

Other names: BCT

Primary outcomes

  1. Diagnostic accuracy

    Time frame: 12 months after completion of accrual

    The diagnostic accuracy of BCT will be determined from a multi-reader, multi-case reader study.

Study contacts

Contact information is provided by the study sponsor or research team.

Michele Galvan, R.T.R.

CONTACT

[email protected]

520-626-2279

Sponsors and collaborators

Lead sponsor

University of Arizona

Other

Collaborators

  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)

Registry information

Official study title

Study of High-resolution, Lower Dose Dedicated Breast CT.

Acronym: LowerDoseBCT

Important dates

Study start
2025
Primary completion
2028
Study completion
2029
First posted
May 17, 2019
Registry last updated
Aug 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.